← Leaderboards
Angela D Bryan
University Of Colorado
$28,316,414
Attributed
$31,657,198
Total exposure
25
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,657,198 · 25
By mechanism
R01$27,545,774 · 11
R33$1,430,111 · 2
P50$892,556 · 1
R61$729,334 · 1
R21$488,591 · 1
R03$295,588 · 2
Top collaborators
- Sarah W. Feldstein Ewing5 shared
- Vijay A Mittal5 shared
- Kent E Hutchison4 shared
Most similar at University Of Colorado
Same institution · by research overlap
- L. Cinnamon Bidwell$10,727,430
- Rachel Erin Thayer$139,433
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignBaseParticipantAdultMediatingExerciseResponseBehaviorReportingHigh RiskLinkPublic HealthBehavioralPrevalenceBiologicalRandomizedNeurocognitiveControl GroupsPsychologicDecision MakingBiological MarkersProgramsCannabidiolCannabinoids
Grant awards (76)
Exercise adherence and cognitive decline: Engaging with the Black community to develop and test a goal-setting and exercise intensity intervention$741,511
R33 · FY2025 · AG · contact PI
Cannabidiol for Individuals at Risk for Alzheimer's Disease: A Randomized Placebo Controlled Trial$700,472
R01 · FY2025 · AG
Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC$649,881
R01 · FY2025 · CA · contact PI
Cannabis use among older adults: Potential risks and benefits to an aging population$572,411
R01 · FY2025 · AG · contact PI
Cannabidiol and Older Adult Cannabis Users: A Randomized, Placebo Controlled Study$446,278
P50 · FY2025 · DA · contact PI
Cannabidiol for Individuals at Risk for Alzheimer's Disease: A Randomized Placebo Controlled Trial$709,313
R01 · FY2024 · AG
Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC$614,341
R01 · FY2024 · CA · contact PI
Cannabis use among older adults: Potential risks and benefits to an aging population$597,205
R01 · FY2024 · AG · contact PI
Cannabidiol and Older Adult Cannabis Users: A Randomized, Placebo Controlled Study$446,278
P50 · FY2024 · DA · contact PI
Exercise adherence and cognitive decline: Engaging with the Black community to develop and test a goal-setting and exercise intensity intervention$349,917
R61 · FY2024 · AG · contact PI
Cannabidiol for Individuals at Risk for Alzheimer's Disease: A Randomized Placebo Controlled Trial$733,468
R01 · FY2023 · AG
Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC$650,978
R01 · FY2023 · CA · contact PI
Cannabis use among older adults: Potential risks and benefits to an aging population$608,509
R01 · FY2023 · AG · contact PI
Exploring the anti-inflammatory properties of cannabis and their relevance to insulin sensitivity$545,270
R01 · FY2023 · DA · contact PI
Exercise adherence and cognitive decline: Engaging with the Black community to develop and test a goal-setting and exercise intensity intervention$379,417
R61 · FY2023 · AG · contact PI
Cannabis use among older adults: Potential risks and benefits to an aging population$618,934
R01 · FY2022 · AG · contact PI
Exploring the anti-inflammatory properties of cannabis and their relevance to insulin sensitivity$545,270
R01 · FY2022 · DA · contact PI
Cannabis use among older adults: Potential risks and benefits to an aging population$658,226
R01 · FY2021 · AG · contact PI
Exploring the anti-inflammatory properties of cannabis and their relevance to insulin sensitivity$545,270
R01 · FY2021 · DA · contact PI
Exploring the anti-inflammatory properties of cannabis and their relevance to insulin sensitivity$16,287
R01 · FY2021 · DA · contact PI
Exploring the anti-inflammatory properties of cannabis and their relevance to insulin sensitivity$555,174
R01 · FY2020 · DA · contact PI
Exploring the anti-inflammatory properties of cannabis and their relevance to insulin sensitivity$571,113
R01 · FY2019 · DA · contact PI
Enhancing function in later life: Exercise and functional network connectivity$557,779
R01 · FY2018 · AG · contact PI
Exercise and markers of medial temporal health in youth at-risk for psychosis$220,977
R33 · FY2018 · MH
Enhancing function in later life: Exercise and functional network connectivity$557,779
R01 · FY2017 · AG · contact PI
Exercise and markers of medial temporal health in youth at-risk for psychosis$229,133
R33 · FY2017 · MH
Enhancing function in later life: Exercise and functional network connectivity$115,976
R01 · FY2017 · AG · contact PI
Enhancing function in later life: Exercise and functional network connectivity$555,903
R01 · FY2016 · AG · contact PI
(PQA-5) DNA methylation and cancer prevention: duration and intensity of exercise$513,435
R01 · FY2016 · CA · contact PI
Exercise and markers of medial temporal health in youth at-risk for psychosis$238,490
R33 · FY2016 · MH
Enhancing function in later life: Exercise and functional network connectivity$581,967
R01 · FY2015 · AG · contact PI
(PQA-5) DNA methylation and cancer prevention: duration and intensity of exercise$525,787
R01 · FY2015 · CA · contact PI
Adolescent decision making and HIV risk avoidance: Neurocognitive factors$511,665
R01 · FY2015 · NR
Exercise and markers of medial temporal health in youth at-risk for psychosis$243,148
R21 · FY2015 · MH
Adolescent decision making and HIV risk avoidance: Neurocognitive factors$527,620
R01 · FY2014 · NR
Enhancing function in later life: Exercise and functional network connectivity$522,945
R01 · FY2014 · AG · contact PI
(PQA-5) DNA methylation and cancer prevention: duration and intensity of exercise$514,066
R01 · FY2014 · CA · contact PI
Exercise and markers of medial temporal health in youth at-risk for psychosis$245,443
R21 · FY2014 · MH
(PQA-5) DNA methylation and cancer prevention: duration and intensity of exercise$559,672
R01 · FY2013 · CA · contact PI
Adolescent decision making and HIV risk avoidance: Neurocognitive factors$516,985
R01 · FY2013 · NR
Alcohol, Marijuana, and Risky Sex: Group Interventions with Detained Adolescents$503,074
R01 · FY2013 · AA · contact PI
Alcohol, Marijuana, and Risky Sex: Group Interventions with Detained Adolescents$602,108
R01 · FY2012 · AA · contact PI
Adolescent decision making and HIV risk avoidance: Neurocognitive factors$568,670
R01 · FY2012 · NR
Alcohol, Marijuana, and Risky Sex: Group Interventions with Detained Adolescents$637,266
R01 · FY2011 · AA · contact PI
Adolescent decision making and HIV risk avoidance: Neurocognitive factors$585,206
R01 · FY2011 · NR
HIV prevention with adolescents: Neurocognitive deficits and treatment response$532,107
R01 · FY2011 · AA · contact PI
Alcohol, Marijuana, and Risky Sex: Group Interventions with Detained Adolescents$677,957
R01 · FY2010 · AA · contact PI
HIV prevention with adolescents: Neurocognitive deficits and treatment response$621,132
R01 · FY2010 · AA · contact PI
Alcohol, Marijuana, and Risky Sex: Group Interventions with Detained Adolescents$682,596
R01 · FY2009 · AA · contact PI
HIV prevention with adolescents: Neurocognitive deficits and treatment response$625,749
R01 · FY2009 · AA · contact PI
HIV prevention with adolescents: Neurocognitive deficits and treatment response$125,637
R01 · FY2009 · AA · contact PI
HIV prevention with adolescents: Neurocognitive deficits and treatment response$613,148
R01 · FY2008 · AA · contact PI
MEDIATORS AND MODERATORS OF EXERCISE BEHAVIOR CHANGE$18,233
M01 · FY2008 · RR · contact PI
MEDIATORS AND MODERATORS OF EXERCISE BEHAVIOR CHANGE$237
M01 · FY2008 · RR · contact PI
HIV prevention with adolescents: Neurocognitive deficits and treatment response$595,425
R01 · FY2007 · AA · contact PI
Marijuana use, gender, and adolescent HIV sexual risk$295,940
R01 · FY2007 · DA · contact PI
MEDIATORS AND MODERATORS OF EXERCISE BEHAVIOR CHANGE$116,134
M01 · FY2007 · RR · contact PI
MEDIATORS AND MODERATORS OF EXERCISE BEHAVIOR CHANGE$2,020
M01 · FY2007 · RR · contact PI
Marijuana use, gender, and adolescent HIV sexual risk$361,381
R01 · FY2006 · DA · contact PI
Mediators and Moderators of Exercise Behavior Change$358,023
R01 · FY2006 · CA · contact PI
MEDIATORS AND MODERATORS OF EXERCISE BEHAVIOR CHANGE$53,223
M01 · FY2006 · RR · contact PI
STUDY OF RESPONSES TO EXERCISE 2$1,857
M01 · FY2006 · RR · contact PI
Marijuana use, gender, and adolescent HIV sexual risk$370,148
R01 · FY2005 · DA
Mediators and Moderators of Exercise Behavior Change$345,993
R01 · FY2005 · CA
Alcohol Use and HIV Risk: An Intervention$333,327
R01 · FY2005 · AA
STUDY OF RESPONSES TO EXERCISE 2$81,493
M01 · FY2005 · RR
Marijuana use, gender, and adolescent HIV sexual risk$368,990
R01 · FY2004 · DA
Mediators and Moderators of Exercise Behavior Change$367,051
R01 · FY2004 · CA
Alcohol Use and HIV Risk: An Intervention$332,461
R01 · FY2004 · AA
Developing Endophenotypes for Responses to Exercise$74,188
R03 · FY2004 · CA
Study of Responses to Exercise 2$2,047
M01 · FY2004 · RR
Alcohol Use and HIV Risk: An Intervention$331,408
R01 · FY2003 · AA
Developing Endophenotypes for Responses to Exercise$74,000
R03 · FY2003 · CA
Alcohol Use and HIV Risk: An Intervention$257,276
R01 · FY2002 · AA
ALCOHOL USE AND HIV RISK AMONG ADOLESCENTS ON PROBATION$73,700
R03 · FY2001 · AA
ALCOHOL USE AND HIV RISK AMONG ADOLESCENTS ON PROBATION$73,700
R03 · FY2000 · AA